Schedule 13G ownership disclosure

METAGENOMI THERAPEUTICS INC

Security class unavailable · CUSIP: 59102M104

Event date: 2024-02-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
581,577
Percent of class
1.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-060040
Form type
SC 13G
Filer
Metagenomi Therapeutics, Inc.
CIK
CIK 1785279
Filed
May 10, 2024
Reporting period
Feb 09, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub